Nestle to Acquire Zenpep From Allergan
January 27 2020 - 2:01AM
Dow Jones News
By Giulia Petroni
Nestle SA (NESN.EB) said Monday that it has entered into an
agreement with Allergan PLC (AGN) to acquire gastrointestinal
medication Zenpep.
"This move aims to expand the company's medical-nutrition
business and complement its portfolio of therapeutic products," the
Swiss food-and-beverage company said.
The acquisition is expected to be finalized concurrent with the
merger of Allergan and AbbVie Inc. (ABBV), according to Nestle.
Financial details of the deal weren't disclosed.
Available in the U.S., Zenpep is a medication for people who
can't digest food properly due to the deficiency of digestive
enzymes made by the pancreas.
Write to Giulia Petroni at giulia.petroni@wsj.com
(END) Dow Jones Newswires
January 27, 2020 01:46 ET (06:46 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Allergan (NYSE:AGN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Allergan (NYSE:AGN)
Historical Stock Chart
From Sep 2023 to Sep 2024